April 21, 2026
Market insights predict the global biologics CDMO industry will increase from USD 22 billion in 2024 to USD 92.79 billion by 2034, achieving a CAGR of 15.48%. In 2024, North America led the biologics CDMO market with 37% share. Asia-Pacific is expect...
February 03, 2026
According to market projections, the biologics sector is expected to grow from USD 485.19 billion in 2025 to USD 1009.33 billion by 2035, reflecting a CAGR of 7.6%. Biologics are advanced medicines made from living cells or organisms. They include va...
April 21, 2026
According to market projections, the biologics contract research organization sector is expected to grow from USD 31.15 billion in 2024 to USD 106.28 billion by 2034, reflecting a CAGR of 13.04%.The market is growing due to the rising demand for biol...
April 21, 2026
Market insights predict, the biologics safety testing industry is expected to grow from USD 4.03 billion in 2024 to USD 14.45 billion by 2034, driven by a CAGR of 13.64%. The growing demand for biologics and growing research and development activitie...
April 21, 2026
Projections indicate that, the global Latin America life science market will increase from USD 4.49 billion in 2024 to USD 12.05 billion by 2034, experiencing a CAGR of 10.38% over the next 10 years. The market is expanding rapidly due to rising R&am...
April 24, 2026
Central Lab Market (By Service Type: Safety Testing, Specialty Testing & Biomarkers, Genomic & Molecular Testing, Pathology & Histology Services, Microbiology & Virology, Clinical Supply Chain & Biorepository; By Therapeutic Area:...
April 21, 2026
Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of t...
February 17, 2026
According to our market projections, the global filtration in biologics market, valued at USD 8.44 billion in 2025, is anticipated to reach USD 29.01 billion by 2035, growing at a CAGR of 13.14% over the next decade. North America was dominant w...
February 17, 2026
According to market projections, the subcutaneous biologics sector is expected to grow from USD 2.1 billion in 2025 to USD 6.01 billion by 2035, reflecting a CAGR of 11.09%. The growing demand for self-administration and the need for targeted therapy...
April 21, 2026
According to market projections, the global cancer biologics market, valued at USD 110.91 billion in 2024, is anticipated to reach USD 232.02 billion by 2034, growing at a CAGR of 7.66% over the next decade. Rising cancer research is anticipated...
February 23, 2026
Based on our estimations, the inhalable biologics market was valued at USD 4.51 billion in 2025 and is projected to reach USD 5.3 billion in 2026, further expanding to USD 22.87 billion by 2035, registering a CAGR of 17.64% during 2026–2035....
April 21, 2026
According to market projections, the global retinal biologics market, valued at USD 25.02 billion in 2024, is anticipated to reach USD 53.61 billion by 2034, growing at a CAGR of 7.92% over the next decade. The growing geriatric population drives the...
April 21, 2026
Market insights predict, the myasthenia gravis industry is expected to grow from USD 1.45 billion in 2024 to USD 2.95 billion by 2034, driven by a CAGR of 7.35%. In 2024, North America led the myasthenia gravis market, with Asia Pacific set for the f...
April 21, 2026
Based on market forecasts, the spine biologics sector will expand from USD 4.42 billion in 2024 to USD 7.34 billion by 2034, experiencing a CAGR of 5.20%. Key drivers of the market's expansion include the rising incidence of degenerative spine illnes...
April 21, 2026
Projections indicate that, the global pharmaceutical stability & storage services market will increase from USD 3.4 billion in 2024 to USD 5.92 billion by 2034, experiencing a CAGR of 5.7% over the next 10 years. The compliance with global standa...
April 14, 2026
Pharmaceutical CRO and CDMO Market ( By CRO: Clinical Research Services, Preclinical Research Services, Clinical Data Management, Bioanalytical Testing Services, Clinical Trial Logistics and Supply Chain Management; By CDMO: Formulation Development...
April 21, 2026
The U.S. residual DNA testing market is growing because increasing application of this testing in forensics and criminal investigations, immigration, infidelity, and paternity....
April 21, 2026
Based on market forecasts, the global pharmaceutical logistic market, projected at USD 111.45 million in 2024, is expected to reach USD 191.1 million by 2034, growing at a CAGR of 5.54% over the forecast period. The demand for efficient and timely de...
April 21, 2026
Projections indicate that, the global immortalized cell line market will increase from USD 4.55 billion in 2024 to USD 8.68 billion by 2034, experiencing a CAGR of 6.71% over the next 10 years.The market is growing due to increasing demand for stable...
April 21, 2026
According to market projections, the cell culture sector is expected to grow from USD 20.61 billion in 2024 to USD 60.38 billion by 2034, reflecting a CAGR of 11.35%. The increasing incidences of chronic disorders, growing research and development,...
April 21, 2026
The next-generation therapy market is expanding due to increasing use of cell and gene therapies as well as rising developments in RNA-based therapies. North America led the market due to the robust industries....
April 21, 2026
According to forecasts, the global pharmaceutical drying equipment market will grow from USD 5.84 billion in 2024 to USD 11.64 billion by 2034, with an expected CAGR of 7.14%. Rising demand for biologics and vaccines is estimated to drive the growt...
April 21, 2026
The life science CDMO market is expanding due to it offers inclusive services from drug development through drug manufacturing, and it majorly focuses on affordability and sustainability by reducing the environmental impact, patient-centric approache...
March 13, 2026
Market insights predict, the orthopedic devices industry is expected to grow from USD 65.8 billion in 2025 to USD 100.63 billion by 2035, driven by a CAGR of 4.34%. The rising prevalence of orthopedic disorders and advancements in medical devices are...
+1 9197 992 333
+91 93077 85324
sales@towardshealthcare.com